Not recruiting
Amyotrophic lateral sclerosis
Not recruitingStudy on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)
Investigational
Study on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)
Investigational
- Disease:Amyotrophic lateral sclerosis
- Substances:Anti-(Misfolded Human Superoxide Dismutase 1) Human Igg1M3 Monoclonal Antibody
Countries:
Sweden
Sweden- Participants:18–64 years · 65+ years
- Substances:Anti-(Misfolded Human Superoxide Dismutase 1) Human Igg1M3 Monoclonal Antibody
